BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 580012)

  • 1. [Contribution to the pharmacology of a novel neuroleptic drug: flupenthixol (author's transl)].
    van den Driessche J
    Arzneimittelforschung; 1977; 27(11):2121-5. PubMed ID: 580012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of alaphen on some functions of central nervous system].
    Masiuta GF
    Farmakol Toksikol; 1966; 29(5):524-7. PubMed ID: 5995061
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relation between chemical constitution and some central properties. 3. Substituted cyclohexylamines].
    Buchel L; Levy J; Tanguy O
    Therapie; 1968; 23(3):619-25. PubMed ID: 5740626
    [No Abstract]   [Full Text] [Related]  

  • 5. Central action of drugs affecting beta-adrenergic receptor. II. The central action of intraventricularly applicated propranolol in rats.
    Ksiazek A; Kleinrok Z
    Pol J Pharmacol Pharm; 1974; 26(3):297-304. PubMed ID: 4859243
    [No Abstract]   [Full Text] [Related]  

  • 6. The central action of beta-adrenergic receptor blocking agents. I. The central action of intraventricularly administered isoprenaline in the rat.
    Ksiazek A; Kleinrok Z
    Pol J Pharmacol Pharm; 1974; 26(3):287-95. PubMed ID: 4859523
    [No Abstract]   [Full Text] [Related]  

  • 7. [General pharmacologic studies on the analgesic flupirtine].
    Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
    Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of 1-brom-1,1-dinitro-4-phenylbutandiol-3,4].
    Chasovskaia IE
    Farmakol Toksikol; 1969; 32(4):442-5. PubMed ID: 4391080
    [No Abstract]   [Full Text] [Related]  

  • 9. Central action of new derivatives of tetrahydropirimidinedione-4,6.
    Wilimowski M; Witkowska M; Kedzierska L; Barczyńska J; Wojewódzki W; Felsztyńska J
    Arch Immunol Ther Exp (Warsz); 1979; 27(3):397-405. PubMed ID: 475560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of the pharmacological effect of oxyphenamate].
    Gorshkova VK; Mikhaĭlova TV; Gilev AP
    Farmakol Toksikol; 1970; 33(3):264-7. PubMed ID: 5465696
    [No Abstract]   [Full Text] [Related]  

  • 11. [Demonstration of a depressive component in the central effects of nikethamide].
    Buchel L; Absil J
    Arch Sci Physiol (Paris); 1972; 26(2):175-94. PubMed ID: 4265482
    [No Abstract]   [Full Text] [Related]  

  • 12. The central action of histamine. II. The effect of intraventricular histamine on the action of some drugs and on the level of biogenic amines in the rat brain.
    Jagiello-Wójtowicz E
    Pol J Pharmacol Pharm; 1973; 25(6):511-8. PubMed ID: 4792475
    [No Abstract]   [Full Text] [Related]  

  • 13. Central action of new imido derivatives of succinic acid.
    Wilimowski M; Witkowska M; Barczyńska J; Kedzierska L; Wojewodzki W; Felsztyńska J
    Arch Immunol Ther Exp (Warsz); 1979; 27(3):389-96. PubMed ID: 475559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety pharmacology of CKD-602, a novel anticancer agent.
    Kim EJ; Lee RK; Suh JE; Han SS; Kim JK
    Arzneimittelforschung; 2003; 53(4):272-9. PubMed ID: 12785124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain.
    Zebrowska-Lupina I; Kleinrok Z; Poddubiuk Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):485-95. PubMed ID: 1172421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [RELATIONS BETWEEN CHEMICAL CONSTITUTION AND SOME CENTRAL PHARMACOLOGICAL PROPERTIES. I. CYCLOHEXYLAMINES WITH THE GENERAL FORMULA C6H10-X-(CH2)N-N--].
    BUCHEL L; GUYONNEAU M
    Therapie; 1963; 18():953-67. PubMed ID: 14069333
    [No Abstract]   [Full Text] [Related]  

  • 17. [The action of isoprothane in combination with amidopyrine].
    Zorian EV
    Farmakol Toksikol; 1970; 33(5):518-21. PubMed ID: 5493211
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha-flupenthixol-induced hyperactivity by chronic dosing in rats.
    Sahakian BJ; Robbins TW; Iversen SD
    Eur J Pharmacol; 1976 May; 37(1):169-78. PubMed ID: 945170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some chemical and pharmacological properties of 2-methyl-5H(1)benzopyrano(2,3-b) pyrid-5-one.
    Nantka-Namirski P; Piechaczek J
    Pol J Pharmacol Pharm; 1976; 28(1):89-94. PubMed ID: 944439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical, pharmacological, and metabolic considerations on thiothixene. Introduction: chemical and pharmacological relationship of thioxanthenes and phenothiazines.
    Weissman A
    Adv Biochem Psychopharmacol; 1974; 9(0):471-80. PubMed ID: 4151768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.